AACC in the News

2015

Here is a sampling of 2015 media coverage of AACC, its journals Clinical Chemistry and The Journal of Applied Laboratory Medicine, and its patient health site, www.labtestsonline.org.

The Theranos Scandal Should Be a Wake-Up Call. Here Are 4 Reasons It Won’t Be
DEC.30.2015 // STAT
Not even the holiday slowdown could bring a reprieve for the beleaguered blood-testing company Theranos.

Theranos’ Proprietary Tech Wasn’t Vetted by Federal Inspectors for Two Years
DEC.30.2015 // The Verge
Theranos, the Silicon Valley blood testing company, launched its first blood-sampling center at the end of 2013. But for most of the two years that followed, federal officials didn’t inspect Theranos’ inventions at all, The Verge has learned.

Can Elizabeth Holmes Save Her Unicorn?
DEC.10.2015 // Bloomberg Businessweek
“Typically companies will show their product at a professional meeting, talk about it, their scientist will present data. Theranos has chosen not to do that, which in my mind is dubious,” says David Koch, president of the American Association for Clinical Chemistry and a professor at Emory University.

Brunswick Mom Donates Part of Liver to Save Infant Son
DEC.7.2015 // The Medina-Gazette
During an INR blood-clotting test, Brodie scored a 9+. The average score is 0.9 to 1.1, according to the American Association for Clinical Chemistry.

How to Optimize Antidiabetic Pharmacotherapy Using the Clinical Significance of HbA1c Variations
NOV.20.2015 // Diabetes in Control
The American Association for Clinical Chemistry recently held a free, informative webinar about HbA1c.

Roche Rapid Flu MDx Test Shown to Impact Patient Care in ER
NOV.5.2015 // Genome Web
Roche's Cobas Liat molecular flu assay is a rapid, adaptable, and sensitive assay that can impact patient care in the emergency room setting.

Here's Why the Jury Is Still Out on Theranos
OCT.27.2015 // Tech Insider
Medical diagnostic and blood testing company Theranos has had a rough couple of weeks, and people want to know how things are going to shake out.

FDA Inspector Slams Theranos for Poor Quality Management
OCT.27.2015 // The Verge
The US Food and Drug Administration today issued two reports, both of a type called a Form 483, which documented the problems the agency found at Theranos, the notoriously secretive blood testing company.

Theranos Doesn’t Want Its Tech Compared to Other Machines — Except When It’s Convenient
OCT.23.2015 // The Verge
Theranos, the hot Silicon Valley blood testing company that’s now under scrutiny after a blockbuster Wall Street Journal article, replied with 6,000 words yesterday claiming that the Journal got their reporting wrong.

This Isn't the First Time People Have Raised Troubling Questions About Theranos
OCT.16.2015 // Business Insider Australia
Faster, cheaper, better. An innovation that accomplishes those three things has the potential to disrupt an industry. But such innovations are rare.

Here's What We Know About How Theranos' 'Revolutionary' Technology Works
OCT.16.2015 // Tech Insider
On October 15, an investigative report by The Wall Street Journal said that hot startup Theranos, founded by Elizabeth Holmes, was mostly relying on traditional technology to analyze blood-test results.

This Isn't the First Time People Have Raised Troubling Questions About Theranos
OCT.15.2015 // Tech Insider
Faster, cheaper, better. An innovation that accomplishes those three things has the potential to disrupt an industry. But such innovations are rare.

From the Editor: Make No Mistake
OCT.12.2015 // Clinical Lab Products
Pathology and laboratory medicine organizations wasted little time before responding to the recent publication by the Institute of Medicine (now a unit of the National Academy of Medicine) on the subject of diagnostic errors.

People in the News: Michael Bennett, David Teitel, and More
OCT.09.2015 // Genome Web
The American Association for Clinical Chemistry announced that Michael Bennett has been elected president-elect.

Hair Follicle Drug Tests Can Lead To A False Positive, Thanks To Secondhand Traces Of Marijuana
OCT.09.2015 // Medical Daily
Though sometimes hair tests are used in the United States, the American Association for Clinical Chemistry suggests that urine tests are the most frequently used drug screens.

New Blood Test Is 99.6% Accurate, Safely Identifies Patients At Low Risk Of Heart Attack
OCT.08.2015 // Medical Daily
A high troponin level or even slight elevation can indicate injury to the heart, according to the American Association for Clinical Chemistry.

AACC Urges CMS to Delay Enforcing Glucose Monitor Regulations
OCT.01.2015 // Medical Laboratory Observer
The American Association for Clinical Chemistry (AACC) has sent a formal comment letter to the Centers for Medicare and Medicaid Services (CMS) addressing CMS’ proposal to enforce more stringent regulatory requirements for in-patient and outpatient hospital testing with blood glucose monitors.

Clinical Laboratories and the Future of Antimicrobials
SEP.29.2015 // USA Today: Future of Personal Health
Using the latest diagnostic tests, clinical laboratory professionals enable doctors to determine whether antibiotics are needed, and choose the right ones for optimal patient outcomes.

Podcast: David Koch and Rebecca Cooney Discuss the IOM Report on Diagnostic Errors
SEP.28.2015 // The Lancet
Improving the quality of care is a constant challenge in American health, and one previously underappreciated area of patient safety is how we assess and reduce the number of diagnostic errors.

Fear of Overtesting and Malpractice Often Drives Diagnostic Errors
SEP.28.2015 // Fierce Healthcare
One reason for the widespread problem of diagnostic errors is the pressure clinicians are under to avoid unnecessary tests and control healthcare costs, according to a leading healthcare expert who was one of the reviewers of the recent Institute of Medicine (IOM) report that revealed most people will experience a misdiagnosis at some point in their lives.

Medical Labs Can Help Prevent Diagnostic Errors
SEP.27.2015 // The Washington Post
The Sept. 23 news article “Study: Most Americans will get at least one wrong diagnosis,” about a recent report from the Institute of Medicine, highlighted the danger and costs that every patient faces.

Landmark Report Urges Reform to Avert Diagnostic Errors
SEP.22.2015 // Medscape
Authors of a landmark report find that little progress has been made in reducing diagnostic errors in the 15 years since the Institute of Medicine's (IOM) report To Err is Human: Building A Safer Health System revealed dramatic lapses in patient safety.

What Are the Different Types of Cholesterol: Which One Is Bad?
SEP.17.2015 // Healthline
Although cholesterol is a naturally occurring substance that’s needed to build healthy cells in the body and keep it functioning properly, too much cholesterol can increase your risk of cardiovascular disease.

Beckman Coulter Diagnostics Receives 2015 Scientists' Choice Award for Best New Clinical Laboratory Product
SEP.11.2015 // Advance
Beckman Coulter Diagnostics' automated Access AntiMüllerian Hormone (AMH) assay was recently selected as the Best New Clinical Laboratory Product of 2014 for the 2015 Scientists' Choice Award by members of SelectScience.

New Diagnostic Tests Serve the Underserved
SEP.10.2015 // Laboratory Equipment
Newly developed point-of-care clinical tests are faster and more affordable, bringing heath care to the masses.

Atlanta Hotels Reach Record Occupancy Numbers in July
AUG.18.2015 // Atlanta Sun Times
Atlanta hotels put up fire-cracking numbers in July, reaching 80 percent occupancy within city limits, according to recent data by the Atlanta Convention & Visitors Bureau.

That’s a Wrap, AACC 2015
AUG.11.2015 // CLP Magazine
The 2015 annual meeting of the American Association for Clinical Chemistry (AACC) saw more than 400 educational sessions, more than 720 exhibitors, and attendance by more than 17,500 medical professionals and healthcare leaders.

New Smartphone DNA Test for Chlamydia is Fast, Inexpensive
AUG.06.2015 // Consultant360
A novel smartphone test that can detect chlamydia with high accuracy could reduce the cost and burden of screening for this highly prevalent sexually transmitted disease, according to new data presented last week at the 2015 American Association for Clinical Chemistry (AACC) Annual Meeting & Clinical Lab Expo in Atlanta.

The Lab Test That Can Do It All
AUG.01.2015 // Daily Rx News
Small labs and clinics in low-income areas often can’t afford state-of-the-art technology, but that might be about to change.

To meet TAT goals, Vanderbilt builds ED lab
AUG.2015 // CAP Today
In a move expected to help meet accreditation standards on testing turnaround times for stroke and chest pain patients, Vanderbilt University Medical Center’s emergency department will gets its own satellite laboratory this month.

First Point-of-Care Device for Routine Clinical Testing
JUL.31.2015 // American Laboratory
A first-of-its-kind point-of-care device can perform routine laboratory tests, examine cholesterol levels to screen for risk of heart disease, and screen for bleeding/monitor treatment for inappropriate blood clotting, and provides results in 3‒10 minutes.

First smartphone DNA test for chlamydia developed
JUL.30.2015 // Business Standard
Researchers have developed a first-of-its-kind smartphone test for chlamydia that can detect the sexually transmitted disease (STD) with high accuracy and is easier and cheaper than current diagnostic methods.

SMARTPHONE DNA TEST FOR CHLAMYDIA DEVELOPED
JUL.30.2015 // Sakshipost
Researchers have developed a first-of-its-kind smartphone test for chlamydia that can detect the sexually transmitted disease (STD) with high accuracy and is easier and cheaper than current diagnostic methods.

Chlamydia screening 'easier and cheaper' with new DNA smartphone test
JUL.30.2015 // Medical News Today
Researchers have created a simple smartphone DNA test that they say can accurately detect chlamydia - the most commonly reported sexually transmitted infection in the US.

First smartphone DNA test for chlamydia developed
JUL.30.2015 // The Economic Times
Researchers have developed a first-of-its-kind smartphone test for chlamydia that can detect the sexually transmitted disease (STD) with high accuracy and is easier and cheaper than current diagnostic methods.

First smartphone DNA test for chlamydia developed
JUL.30.2015 // Lab Medica
Expanded Steroid Control has been launched that now contains nine analytes of interest at clinically relevant levels for mass spectrometry and separation science technology.

Randox woos new customers by hosting workshop in US
JUL.29.2015 // Belfast Telegraph
Northern Ireland medical testing firm Randox has said it hopes to gain new customers as it takes part in the world's largest medical conference in the US.

Indian diagnostics outfit debuts 'lab-on-cartridge' device for developing countries
JUL.29.2015 // Fierce Medical Devices
As the med tech industry homes in on rapid, point-of-care diagnostics geared toward low-income countries, an Indian diagnostics company is developing a "lab-on-cartridge" device that uses inexpensive technology to quickly scan for a host of diseases and conditions.

AACC 2015: New Mobile DNA Test for Chlamydia Announced
JUL.29.2015 // Bioscience Technology
A team of researchers led by Dr. Jeff Tza-Huei Wang from the Johns Hopkins University BioMEMS lab created a new smartphone DNA test capable of diagnosing chlamydia with high accuracy.

Johns Hopkins Researchers Develop Handheld Chlamydia Test Using Microfluidics, Smartphone
JUL.29.2015 // Genome Web
Biomedical engineers at Johns Hopkins University have developed a microfluidic device to enable inexpensive point-of-care molecular testing.

Smartphone DNA Test For Chlamydia Offers Affordable Alternative
JUL.29.2015 // Tech News
Chlamydia is somewhat of a silent STD — most people who are infected are not even aware of it. But if left untreated, it can cause permanent damage.

American Association for Clinical Chemistry: AACC panel says more diagnostics are getting smaller, implantable
JUL.28.2015 // Medical Device Daily
Diagnostics are changing. More sensor-based technologies that can be implanted in the body are emerging and with the addition of an algorithm, smartphones are becoming accurate diagnostic devices.

Hair May Shed Light on Link Between Asthma, Cortisol, Pregnancy Complications
JUL.28.2015 // Laboratory Equipment
Hair samples can be used to measure the effects of asthma on the cortisol levels of women during pregnancy, according to research presented today at the 2015 AACC Annual Meeting & Clinical Lab Expo in Atlanta. This research also shows that levels of cortisol, a stress-related hormone, tend to be lower among pregnant women with asthma than among pregnant women without the chronic, inflammatory lung disease.

Fingernail Tests May Offer Cheap, Simple Way to Diagnose Diabetes
JUL.28.2015 // American Journal of Managed Care
A simple test of fingernail clippings could replace a blood draw as a way to diagnose and monitor type 2 diabetes mellitus (T2DM), with huge implications for tracking the disease the developing world.

AACC 2015: New Tests Could Make Diagnosing Diabetes Easier
JUL.28.2015 // Bioscience Technology
Two new research studies presented at the 2015 American Association for Clinical Chemistry (AACC) Annual Meeting and Lab Expo, show promise for quicker and less-expensive ways to detect diabetes.

Research on rapid Ebola test presented at AACC gathering
JUL.28.2015 // BioPrep Watch
Research that was presented at the American Association for Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Exposition that will expand on a study that procured the rapid test for the Ebola virus, the ACCC announced Monday.

Intelligent Walkaway Clinical Chemistry Analyzer Showcased at AACC
JUL.27.2015 // Lab Medica
A global provider of hematology and clinical chemistry analyzers will display its new economic walkaway clinical chemistry analyzer at the 2015 annual meeting of the American Association of Clinical Chemistry (AACC; Washington DC, USA) in Atlanta (GA, USA) during July 28–30, 2015, in booth 2100.

New Ebola Test Gives Current Gold Standard a Run for Its Money
JUL.27.2015 // MD Magazine
In just 15 minutes an Ebola fingerstick blood test can accurately determine whether a patient is infected with the virus, a team from the Viral Hemorrhagic Fever Consortium reported.

American Association for Clinical Chemistry (AACC) 2015 Annual Meeting & Clinical Lab Expo
JUL.27.2015 // Bioscience Technology
AACC is a global scientific and medical professional organization dedicated to clinical laboratory science and its application to healthcare.

Cepheid readies for 2016 launch of point-of-care molecular Dx system for use anywhere
JUL.27.2015 // Fierce Medical Devices
Diagnostics are not just breaking out of the lab. Now they're about to be available anywhere the patient is with a new device from Cepheid ($CPHD) that it says is the first point-of-care diagnostic device intended for such a broadly defined area of use.

AACC: Better Quality and Patient-Friendliness Needed in Direct Testing
JUL.27.2015 // Fierce Medical Devices
In a new position statement on direct-to-consumer (DTC) laboratory testing, the American Association for Clinical Chemistry (AACC; Washington DC, USA) emphasizes the need for patient-friendly reports and for sufficient transparency about quality of tests and results.

EKF Diagnostics launches new clinical chemistry analyzer at AACC 2015
JUL.23.2015 // News Medical
EKF Diagnostics, the global in vitro diagnostics company, announces the international launch of the Altair™ 240 clinical chemistry analyzer at the American Association for Clinical Chemistry’s (AACC) Annual Meeting and Clinical Lab Expo in Atlanta, Ga, 26-30 July.

The Tech World’s Blood-Test Darling Gets Nods From the FDA
JUL.21.2015 // Wired
The blood test is a cornerstone of modern medicine. In many cases, it provides evidence that turns a bundle of symptoms to a treatable diagnosis. It’s also inconvenient at best, painful at worst, and expensive.

FDA Approves Finger Prick Blood Tests Patients Can Do Without A Lab
JUL.21.2015 // CBS SF Bay Area
Blood tests usually require a prescription, a trip to a lab, hypodermic needles, vials of blood, and a followup visit to the doctor’s office to get the results.

Super-cheap origami disease-testing kit can be printed on demand
JUL.17.2015 // New Scientist
Think of it as origami that could save your life. A sheet of paper can be turned into a personalised diagnostic toolkit using nothing more than an inkjet printer and a few well-placed folds.

Panel Recommends Improvements in Estrogen Testing Accuracy
JUL.16.2015 // MedicalResearch.com
Accurate data on estrogen levels are needed to ensure appropriate and effective patient care.

From the Editor: More Where That Came From
JUL.13.2015 // Clinical Lab Products
Starting with a discussion about AACC’s recent position statement on the role of labs in personalized and precision medicine, Valdes goes on to show just how wide-ranging these trends have become.

Inside Track: Labs Claim a Personal Stake
JUL.10.2015 // Clinical Lab Products
Clinical laboratorians have long recognized the importance of laboratory medicine for guiding decisions related to patient care.

Theranos to partner with Capital BlueCross to provide DTC testing
JUL.9.2015 // Healthcare Dive
Elizabeth Holmes' blood tests have been hailed as great disruptors to healthcare and use continues to expand—although this year she has begun to face some, if not outright criticism, questions.

Mid Cap Stocks To Watch For: TCF Financial Corporation (NYSE:TCB), Cepheid (NASDAQ:CPHD), LendingClub Corp (NYSE:LC), Health Net, Inc. (NYSE:HNT)
JUL.3.2015 // Wall Street Observer
Cepheid (NASDAQ:CPHD) declined -5.05% to end last trading session at $58.04. The company, on June 09, 2015, reported that the company will host a Financial Analyst Event on Monday, July 27th at the 2015 AACC Meeting being held July 26th to 30th in Atlanta, GA.

You may want to touch these 8 adorable looking creatures but beware once you touch them you are dead for sure...
JUL.2.2015 // Moviepilot
According to the toxin library of the American Association of Clinical Chemistry (AACC), this is no simple sting: Intense throbbing pain develops within five minutes of contact, with pain extending up the affected arm.

AACC Calls for Coverage, Reimbursement of Companion Diagnostics
JUN.23.2015 // G2 Intelligence
With “precision medicine” and “personalized medicine” initiatives in the spotlight, the American Association for Clinical Chemistry (AACC) is looking to seize the momentum with a call for policies that ensure access to and appropriate reimbursement for tests that enable tailored treatment.

AACC urges development of and coverage for innovative personalized medicine lab tests
JUN.18.2015 // MLO Online
The American Association for Clinical Chemistry (AACC) has released a position statement endorsing efforts within the healthcare community to improve patient outcomes by personalizing medical care.

AACC recruiting for editor-in-chief of new journal: The Journal of Applied Laboratory Medicine
JUN.18.2015 // Talking New Media
AACC, a global scientific and medical professional organization dedicated to better health through laboratory medicine, is seeking applications for editor-in-chief of a new journal: The Journal of Applied Laboratory Medicine: An AACC Publication.

Estrogen testing accuracy improvements recommended
JUN.13.2015 // Healio
New recommendations were recently released that call for accurate, standardized estrogen testing methods to help improve patient care, according to a statement published in The Journal of Clinical Endocrinology & Metabolism.

Elizabeth Holmes still won't explain how her $9 billion technology actually works
JUN.6.2015 // Business Insider
On June 3, Elizabeth Holmes, the founder and CEO of Theranos, a company that developed a revolutionary blood test that relies only on a drop of blood, appeared on Charlie Rose‘s show to talk about her company and in theory, about some of the science behind it.

The Medical Minute: How Does Alcohol Affect THC Blood Concentration?
JUN.3.2015 // Leafly
If you’re the type of person who likes having a beer in one hand and a joint in the other, you may be interested in this new study from the American Association of Clinical Chemistry (AACC), which found that THC blood concentrations increase significantly with alcohol consumption.

Association Departures and Arrivals (May 29, 2015)
MAY.29.2015 // CEO Update
Lauren Kramer has joined the $18M-revnue American Association for Clinical Chemistry as vice president of education and meetings. She previously was the director of meetings at the International Council of Ophthalmology.

Stoned? Booze Dramatically Increases Your High
MAY.28.2015 // Newser
Marijuana and alcohol are one of the most common drug combinations implicated in car accidents, so researchers at the National Institute on Drug Abuse recently set out to better understand how the two interact.

Marijuana: Cannabis Plus Alcohol Makes for More Dangerous High
MAY.27.2015 // Nature World News
Despite the increased legalization of marijuana, many people are still skeptical of its adverse effects on users.

New Malaria Test Effective for Large-Scale Screening
MAY.20.2015 // Healio
A novel method for malaria testing could achieve large-scale screening and cost-effectiveness that is vital to successful disease control, according to research published in Clinical Chemistry.

Washington-Area Appointments and Promotions for May 18
MAY.17.2015 // The Washington Post
American Association for Clinical Chemistry of the District appointed Lauren Kramer vice president of education and meetings.

New Malaria Test Could Lead to Global Eradication
MAY.13.2015 // Iowa Ag Connection
One of the biggest difficulties faced by worldwide programs aimed at eliminating malaria is that the tests they use are not sensitive enough to detect all people who have the disease and need treatment.

New Malaria Test Could Lead to Global Eradication of the Disease
MAY.12.2015 // Post Online Media
A study appearing online in Clinical Chemistry, the journal of AACC, shows that a new test known as capture and ligation probe-PCR (CLIP-PCR) could diagnose the malaria cases that would typically escape detection and lead to new infections.

At Virology Meeting, Quidel Gives Update on Solana MDx Platform; Researchers Share Data on AmpliVue
APR.29.2015 // GenomeWeb
Clinical diagnostics firm Quidel described improvements it has made to its Solana molecular testing platform, and outlined future menu goals and possible platform improvements during a company-sponsored corporate workshop at the Clinical Virology Symposium here this week.

TS Picks: April 29, 2015
APR.29.2015 // The Scientist
Theranos Chief Executive Officer Elizabeth Holmes has for years touted the promise of her firm’s blood-based diagnostic technology, raising millions of dollars to roll it out on a large scale.

Pharmalot.. Pharmalittle.. Good Morning: We’re Catching Up on Mylan, Teva, Rx Prices, and Lots More!!
APR.27.2015 // The Wall Street Journal
The Theranos blood test could upend the branch of medicine that provides the data used in roughly 70% of medical decisions, but questions remain about how disruptive it may really be because no one knows how it works.

Scientists Are Skeptical About the Secret Blood Test That Has Made Elizabeth Holmes a Billionaire
APR.25.2015 // Business Insider
Theranos, a company founded by Stanford sophomore Elizabeth Holmes in the fall of 2003 (she dropped out a few months later) has generated a lot of buzz for developing a revolutionary approach to the blood test.

Holy Family Memorial Lab Critical to Patient Diagnoses
APR.23.2015 // HTR News
Visit a hospital and you'll likely see nurses checking blood pressure, doctors prescribing medicine or even technicians taking X-rays. But not many see the medical laboratory professionals who are busy analyzing samples from patients that help detect diseases.

Theranos Revolutionizes Preventative Blood Testing So No One Has To Say Goodbye Too Soon
APR.12.2015 // EmpowHER
Imagine a world where people have control over their own health, a place where early detection doesn’t happen accidentally.

Lab Stakeholders Urge CMS Oversight of NGS Tests as FDA Ponders New Reg Scheme
APR.6.2015 // Health Policy News Stand
Key clinical laboratory stakeholders, weighing in on FDA's potential approach to next generation sequencing (NGS) tests, suggest that CMS, as well as CLIA-recognized accrediting bodies and societies, should continue leading the oversight and guidance for NGS testing in most situations.

Startup Aims for Faster Blood Tests
MAR.29.2015 // Arkansas Online
Springdale firm has pregnancy tool approved in U.S.

Online Self Diagnosis: Are You a “Cyberchondriac”?
MAR.23.2015 // The International Post Magazine
Many of us have used the internet at least once to investigate symptoms in order to pin-point a diagnosis of our illness.

AACC Expresses Concerns to FDA Regarding Overregulation of Next-Generation Sequencing Tests
MAR.20.2015 // Healio
The American Association for Clinical Chemistry wrote a formal request letter to the FDA expressing concern about the potential overregulation of next-generation sequencing tests.

Why Routine Blood Tests Often Fail to Detect Low Thyroid Function (And What We Can Do About It)
MAR.10.2015 // Huffington Post
All too often the routine blood tests fail to detect a significant percentage of low thyroid cases.

"Liquid Biopsies" Could Revolutionize Cancer Detection
FEB.28.2015 // Milwaukee Journal Sentinel
In the next year or two, doctors will begin routinely monitoring cancer using a potentially revolutionary technique that searches for a genetic signature in a blood sample, according to experts in the field.

Scientist Convention Steps Aside to Make Way for DNC in 2016
FEB.13.2015 // Philadelphia Business Journal
The American Association for Clinical Chemistry is going to have to find a new time to hold its annual meeting in 2016.

What They're Saying About Philly's DNC Win in New York, Columbus
FEB.13.2015 // Philadelphia Business Journal
In central Ohio, the Columbus Dispatch said the DNC's decision was "deeply disappointing"and that officials there "panned Philadelphia's chances because of labor strife and the fact that the city already had a convention with 18,000 people scheduled for the same time."

AACC to FDA: Don’t Regulate LDTs to Death
FEB.2.2015 // FDA News
The American Association for Clinical Chemistry said Thursday that it shares the FDA’s goal of improving the safety and efficacy of laboratory-developed tests, but that the agency should limit its oversight to higher-risk LDTs that could pose a serious risk to patients if inaccurate.

Doctors Ordering Wrong Vitamin D Test
JAN.29.2015 // HCP Live
When it comes to ordering the correct test for vitamin D, too many doctors just can't get it right, a new study found.

Washington-area appointments and promotions for Jan. 26
JAN.25.2015 // The Washington Post
American Association for Clinical Chemistry of the District appointed Loretta Doan vice president of policy and global affairs.

Association Departures and Arrivals (January 23, 2014)
JAN.23.2015 // CEO Update
The $18M-revenue American Association for Clinical Chemistry has hired Loretta Doan as VP of policy and global affairs, effective Jan. 14.

Will "Liquid Biopsies" Replace Invasive Tissue Biopsies?
JAN.10.2015 // Med Device Online
Using cell-free DNA found in the blood stream, a team led by Vanderbilt researchers has developed a highly accurate method for detecting prostate cancer.

At Workshop, Labs Tell FDA to Let Them Tweak LDTs; Give Their Take on Labeling and Clinical Validity
JAN.9.2015 // GenomeWeb
"The proposal we issued a few months ago, is just that. It's a proposal," Jeff Shuren, director of the US Food and Drug Administration's Center for Devices and Radiological Health, said yesterday at the start of a two-day workshop to discuss the agency's draft guidance on regulation of laboratory-developed tests (LDTs).

Researchers Develop New Blood Test For Prostate Cancer Detection
JAN.9.2015 // Prostate Cancer News Today
A team of international researchers has identified a method that can detect cell-free tumor DNA in a patient’s bloodstream.

Unprescribed Medical Tests Are Themselves a Sign of Trouble
JAN.8.2015 // LA Times
Long Beach resident David Eckhous told me the other day about his mother's experience with an Ohio company called Life Line Screening, which offers unprescribed medical tests that "can help detect hidden health issues before they become a problem."

Nevada commission: Jon Jones tests results show no signs of doping
JAN.8.2015 // Yahoo Sports
Several prominent anti-doping experts publicly suspected UFC light heavyweight champion Jon Jones of using synthetic testosterone after results of a drug test made public earlier this week showed what seemed to be an abnormally low testosterone-to-epitestosterone (T/E) ratio.

Chronix Team Publishes Validation Study of NGS-based Liquid Biopsy Test
JAN.7.2015 // GenomeWeb
Chronix Biomedical has published a clinical validation study of a next-generation sequencing-based test that analyzes circulating cell-free DNA to gauge whether the patient is at high risk for prostate cancer and should go on to receive a biopsy.

Potential Prostate Cancer Blood Test
JAN.7.2015 // Health Canal
Vanderbilt University researcher William Mitchell, MD, PhD, and colleagues in Germany and Canada have demonstrated a method for detecting “cell-free” tumor DNA in the bloodstream.

Italian Team Shows Method for Gene-Expression Profiling of CTCs is Technically Valid, Reliable
JAN.6.2015 // GenomeWeb
A team from the Foundation IRCCS National Cancer Institute in Milan has published a proof of concept of a method for capturing and measuring gene expression in circulating tumor cells, which they hope to use in the clinical care of advanced tumors.

'Liquid Biopsy' Promises to Transform Cancer Screening
JAN.5.2015 // Newsmax Health
An international team of scientists led by Vanderbilt University researchers has devised a new method for detecting "cell-free" tumor DNA in the bloodstream of prostate cancer patients — pointing the way toward development of a “liquid biopsy” that could transform cancer screening.

Watching and Waiting for Codes and Fees
JAN.5.2015 // GEN
Clinical laboratories will be watching and waiting in the new year for the Centers for Medicare and Medicaid Services (CMS) to resolve several unsettled issues concerning fees for molecular pathology tests, as well as coding for drug-screening tests.